These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
580 related articles for article (PubMed ID: 20515296)
1. Impact of insulin delivery devices in diabetes care. Garg SK Diabetes Technol Ther; 2010 Jun; 12 Suppl 1():S1-3. PubMed ID: 20515296 [No Abstract] [Full Text] [Related]
2. [The effect of diabetic treatment on the development and progression of diabetic complications]. Nakai T Nihon Rinsho; 1997 Nov; 55 Suppl():711-20. PubMed ID: 9434553 [No Abstract] [Full Text] [Related]
3. [Application and practice of intensive insulin therapy]. Kishikawa H; Soejima H; Tamama Y; Araki E; Shichiri M Nihon Rinsho; 2002 Sep; 60 Suppl 9():297-303. PubMed ID: 12387009 [No Abstract] [Full Text] [Related]
4. Devices for insulin administration. Hill J Nurs Times; 2003 Apr 15-21; 99(15):51-2. PubMed ID: 12733296 [TBL] [Abstract][Full Text] [Related]
10. Insulin pen use for type 2 diabetes--a clinical perspective. Bailey TS; Edelman SV Diabetes Technol Ther; 2010 Jun; 12 Suppl 1():S86-90. PubMed ID: 20515313 [TBL] [Abstract][Full Text] [Related]
11. Insulin therapy in children and adolescents with diabetes. Galli-Tsinopoulou A Diabetes Res Clin Pract; 2011 Aug; 93 Suppl 1():S114-7. PubMed ID: 21864742 [TBL] [Abstract][Full Text] [Related]
13. Should I consider using an insulin pump to take insulin for type 2 diabetes? Johns Hopkins Med Lett Health After 50; 2004 Aug; 17(6):8. PubMed ID: 15281175 [No Abstract] [Full Text] [Related]
15. Insulin glargine and glulisine SoloSTAR pens for the treatment of diabetes. Garg S; Kelly WC; Garg S Expert Rev Med Devices; 2008 Mar; 5(2):113-23. PubMed ID: 18331174 [TBL] [Abstract][Full Text] [Related]
17. [Practical points in the use of insulin and oral hypoglycemic agents]. Nakayama H Hokkaido Igaku Zasshi; 1989 Jul; 64(4):387-90. PubMed ID: 2684832 [No Abstract] [Full Text] [Related]
18. Dose accuracy and injection force dynamics of a novel disposable insulin pen. Clarke A; Spollett G Expert Opin Drug Deliv; 2007 Mar; 4(2):165-74. PubMed ID: 17335413 [TBL] [Abstract][Full Text] [Related]
19. Optimizing insulin therapy in patients with type 1 and type 2 diabetes mellitus: optimal dosing and timing in the outpatient setting. Hahr AJ; Molitch ME Am J Ther; 2008; 15(6):543-50. PubMed ID: 19127139 [TBL] [Abstract][Full Text] [Related]
20. Health economics and compliance of vials/syringes versus pen devices: a review of the evidence. Asche CV; Shane-McWhorter L; Raparla S Diabetes Technol Ther; 2010 Jun; 12 Suppl 1():S101-8. PubMed ID: 20515297 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]